Drug repurposing for COVID-19: Approaches, challenges and promising candidates
10.1016/j.pharmthera.2021.107930
Saved in:
Main Authors: | Ng, Yan Ling, Salim, Cyrill Kafi, Chu, Justin Jang Hann |
---|---|
Other Authors: | MICROBIOLOGY AND IMMUNOLOGY |
Format: | Review |
Language: | English |
Published: |
PERGAMON-ELSEVIER SCIENCE LTD
2022
|
Subjects: | |
Online Access: | https://scholarbank.nus.edu.sg/handle/10635/235430 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Language: | English |
Similar Items
-
Development and characterization of a SARS-coronavirus replicon cell line
by: GE FENG
Published: (2010) -
A mouse model of lethal respiratory dysfunction for SARS-CoV-2 infection
by: Gan, Esther S., et al.
Published: (2022) -
MicroRNAs Bioinformatics Analyses Identifying HDAC Pathway as a Putative Target for Existing Anti?COVID?19 Therapeutics
by: Teodori, L., et al.
Published: (2021) -
Single-Cell RNA-seq Reveals Angiotensin-Converting Enzyme 2 and Transmembrane Serine Protease 2 Expression in TROP2+ Liver Progenitor Cells: Implications in Coronavirus Disease 2019-Associated Liver Dysfunction
by: Seow, Justine Jia Wen, et al.
Published: (2022) -
Repurposing dihydropyridines for treatment of helicobacter pylori infection
by: González, A., et al.
Published: (2022)